241 related articles for article (PubMed ID: 21170883)
1. Perspectives of 1H-NMR-based urinary metabonomics in Fabry disease.
Beneduci A; Cuccurullo M; Pontoni G; Chidichimo G; Capasso G
J Nephrol; 2010; 23 Suppl 16():S213-20. PubMed ID: 21170883
[TBL] [Abstract][Full Text] [Related]
2. [Human amniotic fluid influenced by different sampling methods during 1H NMR-based metabonomics analysis].
Huang H; Wu X; Zhou J; Xu B; Kong X; Huang J; Li W
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Aug; 27(4):731-5. PubMed ID: 20842834
[TBL] [Abstract][Full Text] [Related]
3. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
4. Following dynamic biological processes through NMR-based metabonomics: a new tool in nanomedicine?
Duarte IF
J Control Release; 2011 Jul; 153(1):34-9. PubMed ID: 21406205
[TBL] [Abstract][Full Text] [Related]
5. [Applications of 1H nuclear magnetic resonance spectroscopy and nuclear magnetic resonance-based metabonomics in tumour studies].
Gao HC; Lin DH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):803-10. PubMed ID: 18595263
[TBL] [Abstract][Full Text] [Related]
6. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.
Serkova NJ; Niemann CU
Expert Rev Mol Diagn; 2006 Sep; 6(5):717-31. PubMed ID: 17009906
[TBL] [Abstract][Full Text] [Related]
7. Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery.
Sieber M; Wagner S; Rached E; Amberg A; Mally A; Dekant W
Chem Res Toxicol; 2009 Jul; 22(7):1221-31. PubMed ID: 19610676
[TBL] [Abstract][Full Text] [Related]
8. Potential effect of diaper and cotton ball contamination on NMR- and LC/MS-based metabonomics studies of urine from newborn babies.
Goodpaster AM; Ramadas EH; Kennedy MA
Anal Chem; 2011 Feb; 83(3):896-902. PubMed ID: 21210639
[TBL] [Abstract][Full Text] [Related]
9. Fabry disease: perspectives of urinary proteomics.
Cuccurullo M; Beneduci A; Anand S; Mignani R; Cianciaruso B; Bachi A; Capasso G
J Nephrol; 2010; 23 Suppl 16():S199-212. PubMed ID: 21170881
[TBL] [Abstract][Full Text] [Related]
10. [1H-NMR-based metabonomics analysis of plasma from osteoporotic rats induced by ovariectomy].
Long WF; Li L; Chen HQ; Tang Y; He XL; Jing RZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):843-7. PubMed ID: 19950596
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype.
Calvani R; Miccheli A; Capuani G; Tomassini Miccheli A; Puccetti C; Delfini M; Iaconelli A; Nanni G; Mingrone G
Int J Obes (Lond); 2010 Jun; 34(6):1095-8. PubMed ID: 20212498
[TBL] [Abstract][Full Text] [Related]
12. Statistical significance analysis of nuclear magnetic resonance-based metabonomics data.
Goodpaster AM; Romick-Rosendale LE; Kennedy MA
Anal Biochem; 2010 Jun; 401(1):134-43. PubMed ID: 20159006
[TBL] [Abstract][Full Text] [Related]
13. Establishing ¹H nuclear magnetic resonance based metabonomics fingerprinting profile for spinal cord injury: a pilot study.
Jiang H; Peng J; Zhou ZY; Duan Y; Chen W; Cai B; Yang H; Zhang W
Chin Med J (Engl); 2010 Sep; 123(17):2315-9. PubMed ID: 21034541
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing transgenic from non-transgenic Arabidopsis plants by (1)H NMR-based metabolic fingerprinting.
Ren Y; Wang T; Peng Y; Xia B; Qu LJ
J Genet Genomics; 2009 Oct; 36(10):621-8. PubMed ID: 19840760
[TBL] [Abstract][Full Text] [Related]
16. Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats.
Um SY; Chung MW; Kim KB; Kim SH; Oh JS; Oh HY; Lee HJ; Choi KH
Anal Chem; 2009 Jun; 81(12):4734-41. PubMed ID: 19462990
[TBL] [Abstract][Full Text] [Related]
17. [The effect of non-experimental factors on human nuclear magnetic resonance metabonomics study].
Wu Q; Yu S; Yan X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):204-7. PubMed ID: 18435291
[TBL] [Abstract][Full Text] [Related]
18. Urinary globotriaosylsphingosine-related biomarkers for Fabry disease targeted by metabolomics.
Auray-Blais C; Boutin M; Gagnon R; Dupont FO; Lavoie P; Clarke JT
Anal Chem; 2012 Mar; 84(6):2745-53. PubMed ID: 22309310
[TBL] [Abstract][Full Text] [Related]
19. NMR and MS methods for metabonomics.
Dieterle F; Riefke B; Schlotterbeck G; Ross A; Senn H; Amberg A
Methods Mol Biol; 2011; 691():385-415. PubMed ID: 20972767
[TBL] [Abstract][Full Text] [Related]
20. Lemna minor L. as a model organism for ecotoxicological studies performing 1H NMR fingerprinting.
Aliferis KA; Materzok S; Paziotou GN; Chrysayi-Tokousbalides M
Chemosphere; 2009 Aug; 76(7):967-73. PubMed ID: 19443011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
